Addressing US FDA challenges in Indian sterile drug manufacturing – Part 3 Manish Bhatkar Jun 21, 2025 In this final instalment, Manish Bhatkar, Founder & CEO, RedLotus Pharmtech, transitions from analysis to action. Drawing on…
Addressing US FDA challenges in Indian sterile drug manufacturing – Part 2 Manish Bhatkar Jun 20, 2025 In this second part, Manish Bhatkar, Founder & CEO, RedLotus Pharmtech continues the discussion on FDA expectations, with…
Addressing US FDA challenges in Indian sterile drug manufacturing – Part 1 Manish Bhatkar, Founder & CEO, RedLotus Pharmtech Jun 19, 2025 In the three-part series, Manish Bhatkar, Founder & CEO, RedLotus Pharmtech in this article explores the evolution of India’s…
